EdgarLookup
10-K XBRL

10-K

Company
SELLAS Life Sciences Group, Inc.
Filed
March 23, 2021
Period of Report
December 31, 2020
Accession Number
0001390478-21-000007

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →